These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms]. Bettin S, Kämpfer I, Seese A, Schäfer A, Reuter M, Lössner J, Dietrich J, Wagner A, Knapp WH. Nuklearmedizin; 1997 Aug; 36(5):167-72. PubMed ID: 9380528 [Abstract] [Full Text] [Related]
17. Morphological and functional imaging in neurological and non-neurological Wilson's patients. Hermann W. Ann N Y Acad Sci; 2014 May; 1315():24-9. PubMed ID: 24495036 [Abstract] [Full Text] [Related]
18. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics. Klemm E, Grünwald F, Kasper S, Menzel C, Broich K, Danos P, Reichmann K, Krappel C, Rieker O, Briele B, Hotze AL, Möller HJ, Biersack HJ. Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197 [Abstract] [Full Text] [Related]
19. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability. Verhoeff NP, Kapucu O, Sokole-Busemann E, van Royen EA, Janssen AG. J Nucl Med; 1993 Dec; 34(12):2076-84. PubMed ID: 8254390 [Abstract] [Full Text] [Related]
20. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans. Kung HF, Alavi A, Chang W, Kung MP, Keyes JW, Velchik MG, Billings J, Pan S, Noto R, Rausch. J Nucl Med; 1990 May; 31(5):573-9. PubMed ID: 2140408 [Abstract] [Full Text] [Related] Page: [Next] [New Search]